In a pre-specified subgroup analysis of patients with baseline sPCR ≥1,000 mg/gCr, there was a dose-dependent reduction in sPCR, which did not reach statistical significance.
← all excerpts
An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective.
1
—
—